What you see above is the Asus TF300T, where according to Taiwanese site NCCC, it might actually be the next generation device in the Transformer family. Granted, the Asus Transformer and Transformer Prime did garner their fair bit of attention when announced, but neither has come close to cementing their mark as part of the higher echelons of tablets in the market.
The Asus TF300T is interesting to look at, as this 10.1″ slate has a model number that is numerically higher compared to its Transformer predecessors, where the original is known as the TF101, while the Prime goes by the moniker TF201. Too bad there is no additional information given to us, such as specifications, to make this bit of reporting more juicy to bite into. What we do know is, Asus might be out for blood from their competitors considering the color scheme of the Asus TF300T.
Asus TF300T might be Transformer successor
Global fashion e-tailer Shein launches new hub in Singapore
Digital Revolution and Repression in Myanmar and Thailand
Activists have also proactively published social media content in multiple languages using the hashtags #WhatsHappeningInMyanmar and #WhatsHappeningInThailand to boost coverage of events on the ground.
Subscribe via Email
Asia’s slow rate of vaccination is a thorn in the region’s economic recovery
Southeast Asia has been hit badly. Daily infections for Indonesia, Thailand, Vietnam are at their worst, on a seven-day moving...
TAT expects 850 billion baht ($25.7 bln) in tourism revenue after successful reopening
The Tourism Authority of Thailand (TAT) has set this year’s revenue target at 850 billion baht, 300 billion of which...
Download 1xBet mobile and play all over the world
Placing profitable bets or playing in a casino is now possible comfortably even without being tied to a computer. It...
3 ways Asia can recover from the COVID-19 pandemic faster
Countries in the East Asia and Pacific region will benefit from cooperation in three major areas: vaccine deployment, reviving sectors...
Thailand’s Vaccine Strategy: What went wrong?
Questions are being asked, and not answered, over the decision to rely almost entirely on Siam Bioscience, a local, palace-owned...